Study: Dextera touts shorter hospital stays for MI lobectomy procedures using its MicroCutter stapler

Dextera Surgical (NSDQ:DXTR) today released data from a small study of patients who underwent microlobectomy procedures utilizing its MicroCutter surgical stapler, touting hospital stays at least 2 days lower than open lobectomy procedures.

“The interest in the presentation at the meeting reflects the global interest in technologies like the MicroCutter 5/80 that enable less invasive approaches to lobectomy that may accelerate the adoption of video-assisted thoracic surgery techniques and other surgical procedures,” Dextera worldwide sales and marketing VP Liam Burns said in a press release.

The data came from 82 patients who underwent microlobectomies, the Redwood City, Calif.-based company said, and indicated a median hospital stay of 3 days, with 20.7% of patients discharged the day after surgery. An additional 17% of patients were released 2 days after surgery, the company said.

Results from the study were presented at the Scandinavian Society for Research in Cardiothoracic Surgery 2017 meeting in Geilo, Norway.

“The Microlobectomy procedure, enabled by the MicroCutter 5/80 surgical stapler, due to the slim profile of the five-millimeter diameter with 80 degrees of articulation, reduces postoperative pain and complications compared to traditional open procedures and overall, improves a patient’s recovery after a major lung resection. These data further support what surgeons around the world are experiencing when performing the Microlobectomy – that the less invasive nature of this procedure shortens hospital stays when compared to a traditional open lobectomy, with 20.7% of patients able to return home within 24 hours,” Dr. Marco Nardini of the Middlesbrough, U.K. James Cook University said in a prepared statement.

Last December, Dextera Surgical said it launched a registry study of its MicroCutter 5/80 surgical stapler designed for hemostasis.

The company said it enrolled the 1st U.S. patient in the study, which looks to enroll a total of 120 patients undergoing lung resections which require surgical stapling.

The study will examine the effectiveness of the MicroCutter 5/80 surgical stapler at stopping the flow of blood, or hemostasis, the company said. The registry also aims to evaluate procedure-enabling aspects of the device in lobectomy or segmentectomy lung surgery procedures using minimally invasive techniques, including video assisted thoracic surgeries, robotic surgeries and open surgeries.

The post Study: Dextera touts shorter hospital stays for MI lobectomy procedures using its MicroCutter stapler appeared first on MassDevice.

from MassDevice http://ift.tt/2n7t4pt